TANITHA MONCIER: Open Payments
NPI 1063561181 · MURFREESBORO, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$205 in 12 payments from 8 companies in 2025. Trend: 2023 $542 · 2024 $285 · 2025 $205
Food & beverage: $205
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $48 |
| Corium, LLC | 2 | $36 |
| Vanda Pharmaceuticals Inc. | 2 | $32 |
| Axsome Therapeutics, Inc. | 2 | $30 |
| ABBVIE INC. | 1 | $18 |
| E.R. Squibb & Sons, L.L.C. | 1 | $14 |
| Noven Therapeutics, LLC | 1 | $14 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
Products named: CAPLYTA, Azstarys, FANAPT, Auvelity, VRAYLAR, COBENFY, Xelstrym, REXULTI.
Industry payments across TN — which companies pay providers there.
